Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)

China flag China · Delayed Price · Currency is CNY
19.36
-0.30 (-1.53%)
May 20, 2026, 1:45 PM CST
Market Cap5.61B +110.3%
Revenue (ttm)2.89B +28.1%
Net Income-114.97M
EPS-0.39
Shares Out285.46M
PE Ration/a
Forward PEn/a
Dividend0.07 (0.36%)
Ex-Dividend DateJun 23, 2025
Volume7,551,500
Average Volume19,811,940
Open19.68
Previous Close19.66
Day's Range19.23 - 19.82
52-Week Range9.05 - 32.27
Beta-0.06
RSI36.23
Earnings DateApr 21, 2026

About SHA:600513

Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprilite, danazol suppositories, and terfenadine tablets. It also provides urinary system drugs, including eprepitant tablets, terazosin tablets, and drotave... [Read more]

Sector Healthcare
Founded 1999
Employees 1,388
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600513
Full Company Profile

Financial Performance

Financial Statements